Femasys Inc.
PublicFemasys Inc. is now publicly traded
The data on this page reflects Femasys Inc.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Jun 17, 2021
Last Round
Private Placement
Aug 10, 2026
Total Funding Raised
$144.27M
Company Overview
Femasys Inc. has raised $144.27M. It was founded in 2004.
Femasys Inc. is a biomedical company that develops and commercializes therapeutic and diagnostic products for women's reproductive health needs.
AI Layer
Non-AI
Femasys Inc. Comparables
Compare Femasys Inc. with similar companies based on industry and business-model similarity.
No comparables are published for Femasys Inc.. Book a demo to ask about coverage.
Book a demoFor institutional investors. Book with your work email.
Femasys Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Aug 10, 2026 | ||||
| Follow-on Offering | Sep 2, 2025 | ||||
| Private Placement | Jun 2, 2025 | ||||
| Convertible Debt | Nov 15, 2023 | ||||
| IPO | Jun 17, 2021 | ||||
Series C Extension | Jan 6, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Femasys Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| JonesTrading | Private Placement |
| Rosalind Advisors | Private Placement |
| Salem Partners | Series C Extension, Series B, Series C |
| Chardan | IPO |
| Nantahala Capital Management | Private Placement |
Femasys Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.